Annotation Detail for ZNF426
Basic Information
Top
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ZNF426 mRNA | decreases expression | 20018196
|
| D004958 |
Estradiol |
[Progesterone co-treated with Estradiol] results in decreased expression of ZNF426 mRNA | affects cotreatment|decreases expression | 17404688
|
| D011374 |
Progesterone |
[Progesterone co-treated with Estradiol] results in decreased expression of ZNF426 mRNA | affects cotreatment|decreases expression | 17404688
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
2.18 | 11473722 |
| MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
6.20 | 17868700 |
| MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.91 | 15845082 15665606 15380490 |
| MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.17 | 12948864 17289903 16675129 18497071 19861407 14630087 17018787 17261762 |
| MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
2.17 | 16175315 15562024 17614352 |
| MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
5.21 | 16111702 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
1.79 | 16924424 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7.63 | 20889678 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
7.63 | 18566989 |
| MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.83 | 19279558 |
| MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
5.15 | 17187935 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
4.36 | 17692515 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
3.25 | 11473722 18566989 19148513 |
| MESH:D004715 |
Endometriosis |
|
Progesterone |
4.21 | 16134523 |
| MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.15 | 20426865 |
| MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.90 | 15709030 |
| MESH:D019584 |
Hot Flashes |
|
Estradiol |
4.62 | 17088409 |
| MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
5.05 | 15869954 |
| MESH:D007249 |
Inflammation |
|
Progesterone |
2.79 | 15869954 |
| MESH:D007333 |
Insulin Resistance |
|
Estradiol |
3.23 | 16627594 16393666 |
| MESH:D007674 |
Kidney Diseases |
|
Estradiol |
2.80 | 15618244 |
| MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
3.36 | 15610895 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
1.69 | 14659978 14716833 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
6.95 | 11807958 17203775 16891317 11408345 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
6.95 | 17203775 11408345 |
| MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
5.35 | 19453300 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.62 | 16810080 |
| MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
4.47 | 17289903 |
| MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
4.23 | 11399458 16427766 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
5.23 | 19401270 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
5.23 | 17393432 16525653 |
| MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
4.37 | 20887781 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.02 | 16740699 |
| MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.97 | 18045962 |
| MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
5.02 | 15862959 16503802 |
| MESH:D013978 |
Tibial Fractures |
|
Estradiol |
5.55 | 19048282 |
Related Pathway Information